Breaking Points with Krystal and Saagar Mini Show #13: Pharma Dems, Pete vs Kamala, Tulsi's Shift, John Oliver, and More!
Nov 20, 2021
In this engaging discussion, Andrew Perez, a contributor to The Daily Poster with expertise in Medicare drug pricing, joins Krystal, Saagar, and Kyle Kulinski. They unravel the tangled web of pharmaceutical lobbying, revealing how it shapes legislative outcomes and hampers drug pricing reforms. The hosts explore the intense battle between Kamala Harris and Pete Buttigieg, Tulsi Gabbard’s political evolution, and John Oliver’s coverage of union issues. A thought-provoking look at health policy and political maneuvering awaits!
AI Snips
Chapters
Transcript
Episode notes
Pharma Dems' Big Win
- Pharma Dems saved the drug industry approximately $450 billion.
- Their lobbying spending represents less than 0.1% of this amount.
Potential Successors
- Kamala Harris and Pete Buttigieg are under scrutiny as potential Biden successors.
- Neither is likely to win a national election, according to Saagar Enjeti.
Democratic Priorities
- Democratic elites prioritize maintaining their positions over winning elections, suggests Krystal Ball.
- Pete Buttigieg represents a guarantee for the existing power structure.